胃癌胃切除术后骨密度与骨代谢变化的Meta分析
该Meta分析纳入19项队列研究共1204例患者(802例男性),评估胃癌胃切除术后骨质疏松患病率、骨密度及骨代谢标志物变化。结果显示术后骨质疏松合并患病率为36%(95%CI 32-40),女性风险显著高于男性(OR=1.90,p<0.001),部分与全胃切除间无显著差异(OR=0.983,p=0.939);术后骨密度显著下降,钙、磷、甲状旁腺激素水平显著升高,与对照组相比骨密度及钙、25OH-维生素D水平显著降低,甲状旁腺激素和1,25OH-维生素D水平显著升高。
要点
- 胃癌胃切除术后骨质疏松合并患病率为36%(95%CI 32-40)。
- 女性术后骨质疏松风险显著高于男性(OR=1.90,p<0.001)。
- 术后应长期监测营养与骨骼健康,并考虑营养或药物干预。
核心结论
- 胃癌患者胃切除术后骨密度显著降低,维生素D缺乏和继发性甲状旁腺功能亢进可能是骨密度受损的常见机制。
- 术后除肿瘤随访外,患者应接受长期营养和骨骼健康监测。
研究设计与样本
- 对19项队列研究进行Meta分析,共纳入1204例患者(802例男性)。
- 评估胃切除术后骨质疏松患病率,按胃切除类型和性别比较发生率,并评估术前术后及与匹配对照相比的骨密度和骨代谢相关标志物变化。
- 采用比例Meta分析并计算合并比值比(OR)。
主要发现
- 骨质疏松合并患病率为36%(95%CI 32-40)。
- 女性骨质疏松发生率显著高于男性(OR=1.90,p<0.001),部分胃切除与全胃切除组间无显著差异(OR=0.983,p=0.939)。
- 胃切除术后患者骨密度显著降低,钙、磷、甲状旁腺激素水平较术前显著升高。
- 与对照组相比,胃切除组骨密度及钙、25OH-维生素D水平显著降低,甲状旁腺激素和1,25OH-维生素D水平显著升高。
关键数值与推荐
- 骨质疏松合并患病率36%(95%CI 32-40)。
- 女性与男性骨质疏松风险OR=1.90(p<0.001)。
- 部分与全胃切除组骨质疏松风险OR=0.983(p=0.939)。
临床怎么用
- 胃癌胃切除术后应早期监测骨密度和骨代谢指标。
- 针对维生素D缺乏和继发性甲状旁腺功能亢进,考虑营养或药物强化干预以维护骨骼健康。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Bone mineral density (BMD) is significantly decreased after gastrectomy in patients with gastric cancer. Calcium malabsorption, secondary hyperparathyroidism, and dominant bone resorption appear to contribute to bone loss in these patients. Patients should undergo early surveillance and nutritional or pharmacologic intensive interventions for bone health. PURPOSE: Survivorship care, including bone health, has become an important issue in gastric cancer. We performed a meta-analysis of the available observational studies to determine whether and how osteoporosis risk is increased after gastrectomy in patients with gastric cancer. METHODS: A total of 1204 patients (802 men) from 19 cohort studies were included. We evaluated the prevalence of osteoporosis in postgastrectomy patients, comparing the incidence according to the type of gastrectomy and sex. Additionally, we evaluated changes in bone mineral density (BMD) and bone metabolism-related markers pre- to postoperatively and between patients who underwent gastrectomy and matched controls. Proportion meta-analysis was performed and pooled odds ratios (ORs) were calculated. RESULTS: The pooled incidence estimate was 36% [95% confidence interval (CI), 32-40]. The incidence of osteoporosis was significantly higher in women than in men (OR = 1.90, p < 0.001) but was similar between partial and total gastrectomy groups (OR = 0.983, p = 0.939). BMD was significantly decreased, and calcium, phosphorous, and parathyroid hormone levels were significantly increased in patients after gastrectomy compared to those before gastrectomy. BMD and calcium and 25OH-vitamin D levels were significantly decreased, and parathyroid hormone and 1,25OH-vitamin D levels were significantly increased in the gastrectomy group compared to that in the control group. CONCLUSION: We found that BMD is significantly decreased after gastrectomy in patients with gastric cancer. Vitamin D deficiency and secondary hyperparathyroidism are suggested to be common mechanism underlying BMD impairment. After resection, patients should undergo long-term nutritional and bone health surveillance, in addition to their oncological follow-up.
引用
- Oh HJ, Yoon BH, Ha YC, et al. The change of bone mineral density and bone metabolism after gastrectomy for gastric cancer: a meta-analysis. Osteoporos Int. 2019. PMID: 31776636. doi:10.1007/s00198-019-05220-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。